• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.54% Nasdaq Down1.52%

    Esperion Therapeutics, Inc. (ESPR)

    -NasdaqGM
    101.22 Down 0.13(0.12%) Apr 17, 4:00PM EDT
    |After Hours : 101.23 Up 0.01 (0.01%) Apr 17, 4:34PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue -   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   -  
    Operating Expenses
    Research Development6,200  7,174  6,528  5,400  
    Selling General and Administrative3,180  2,526  2,726  2,490  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (9,380) (9,700) (9,254) (7,890)
    Income from Continuing Operations
    Total Other Income/Expenses Net57  29  17  16  
    Earnings Before Interest And Taxes(9,323)(9,671)(9,237)(7,874)
    Interest Expense134  135  1   -  
    Income Before Tax(9,457)(9,806)(9,238)(7,874)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(9,457)(9,806)(9,238)(7,874)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (9,457) (9,806) (9,238) (7,874)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (9,457) (9,806) (9,238) (7,874)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.